• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

昼夜节律基因NPAS2通过CDC25A介导的成纤维细胞活性减轻肥厚性瘢痕形成。

Circadian Gene NPAS2 Relieves Hypertrophic Scar Formation via CDC25A-Mediated Fibroblasts Activity.

作者信息

Wei Pei, Xiao Yongqiang, Xu Zhaorong, Chen Xiaodong, Jiang Qiong, Fu Yu, Yan Jianji, Chen Zhaohong, Luo Pengfei, Liu Huazhen

机构信息

Burn & Wound Repair Department, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.

Fujian Burn Institute, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.

出版信息

J Cell Mol Med. 2025 Jun;29(12):e70643. doi: 10.1111/jcmm.70643.

DOI:10.1111/jcmm.70643
PMID:40548841
Abstract

Neuronal PAS domain protein 2 (NPAS2) is critical in tissue fibrosis. Hypertrophic scars (HTS), a form of skin fibrosis, are characterised by excessive myofibroblast proliferation and abnormal extracellular matrix (ECM) deposition. However, whether NPAS2 contributes to skin fibrosis and the development of HTS remains unclear. In this study, the expression of NPAS2 between normal skin and hypertrophic scars (HTS) was assessed using RT-qPCR and immunohistochemistry (IHC). Human dermal fibroblasts (HDFs) and HTS-derived fibroblasts (HTS-Fs) were isolated from normal skin and HTS, respectively. NPAS2 was knocked down in HTS-Fs and overexpressed in HDFs via gene transfection. Cell proliferation and migration of transfected HTS-Fs and HDFs were analysed using flow cytometry, CCK-8 and transwell assays. The expressions of NPAS2, CLOCK, BMAL1, COL I, COL III, α-SMA and CDC25A were evaluated by western blotting and RT-qPCR. Dual-luciferase reporter assays and chromatin immunoprecipitation (ChIP) identified the regulatory effect of NPAS2 on CDC25A. In vivo, an 8 × 8 mm full-thickness skin defect was created on the tail of SD rats, with viral particles (1 × 107) of r-plenR-sh-NPAS2 or r-plenR-NPAS2-NC injected subcutaneously at the wound edges weekly. Tissue samples, histopathological analyses and photographs were taken until the wound healed completely. The results indicated that NPAS2 was significantly upregulated in HTS. The proliferation, migration, and expression of COL I, COL III, and α-SMA were higher in HDFs overexpressing NPAS2 than those of HDFs themselves. In contrast, the behaviours mentioned above of HTS-Fs knocking down NPAS2 were lower than that of HTS-Fs. Mechanistically, the migration and proliferation promoting effect of NPAS2 was mediated by the binding of NPAS2 to the E-like-box of CDC25A. In vivo, compared with the r-plenR-NPAS2-NC group, the re-epithelialised regions of r-plenR-sh-NPAS2 were pink, flat and as large as the initial wound. In addition, their dermal structures were similar to skin and possessed loose and regular collagen arrangement which was parallel to the epidermis. Take together, these findings suggested that compared with HDFs, NPAS2 was upregulated in HTS-Fs. NPAS2 promoted the activation of HDFs, which is characterised by stronger proliferation and migration and the higher level of α-SMA, COL I and COL III. In which, the proliferation and migration effects of NPAS2 were mediated by CDC25A. Furthermore, NPAS2 knocked down in rat tail wounds inhibited the HTS formation. Therefore, NPAS2 may serve as a potential therapeutic target for HTS in the future.

摘要

神经元PAS结构域蛋白2(NPAS2)在组织纤维化中起关键作用。肥厚性瘢痕(HTS)是皮肤纤维化的一种形式,其特征在于肌成纤维细胞过度增殖和细胞外基质(ECM)异常沉积。然而,NPAS2是否促成皮肤纤维化和HTS的形成仍不清楚。在本研究中,使用RT-qPCR和免疫组织化学(IHC)评估正常皮肤和肥厚性瘢痕(HTS)中NPAS2的表达。人皮肤成纤维细胞(HDFs)和HTS来源的成纤维细胞(HTS-Fs)分别从正常皮肤和HTS中分离出来。通过基因转染在HTS-Fs中敲低NPAS2,并在HDFs中过表达NPAS2。使用流式细胞术、CCK-8和Transwell试验分析转染的HTS-Fs和HDFs的细胞增殖和迁移。通过蛋白质印迹和RT-qPCR评估NPAS2、CLOCK、BMAL1、COL I、COL III、α-SMA和CDC25A的表达。双荧光素酶报告基因试验和染色质免疫沉淀(ChIP)确定了NPAS2对CDC25A的调节作用。在体内,在SD大鼠尾部制造一个8×8mm的全层皮肤缺损,每周在伤口边缘皮下注射r-plenR-sh-NPAS2或r-plenR-NPAS2-NC的病毒颗粒(1×107)。采集组织样本、进行组织病理学分析并拍照,直到伤口完全愈合。结果表明,NPAS2在HTS中显著上调。过表达NPAS2的HDFs中COL I、COL III和α-SMA的增殖、迁移及表达高于HDFs本身。相反,敲低NPAS2的HTS-Fs的上述行为低于HTS-Fs。机制上,NPAS2的迁移和增殖促进作用是由NPAS2与CDC25A的E样框结合介导的。在体内,与r-plenR-NPAS2-NC组相比,r-plenR-sh-NPAS2组的再上皮化区域呈粉红色、平坦,与初始伤口大小相同。此外,它们的真皮结构类似于皮肤,胶原排列疏松且规则,与表皮平行。综上所述,这些发现表明,与HDFs相比,NPAS2在HTS-Fs中上调。NPAS促HDFs的激活,其特征是更强的增殖和迁移以及更高水平的α-SMA、COL I和COL III。其中,NPAS2的增殖和迁移作用由CDC25A介导。此外,在大鼠尾部伤口中敲低NPAS2可抑制HTS的形成。因此,NPAS2未来可能作为HTS的潜在治疗靶点。

相似文献

1
Circadian Gene NPAS2 Relieves Hypertrophic Scar Formation via CDC25A-Mediated Fibroblasts Activity.昼夜节律基因NPAS2通过CDC25A介导的成纤维细胞活性减轻肥厚性瘢痕形成。
J Cell Mol Med. 2025 Jun;29(12):e70643. doi: 10.1111/jcmm.70643.
2
Methionine Restriction Attenuates Scar Formation in Fibroblasts Derived from Patients with Post-Burn Hypertrophic Scar.蛋氨酸限制可减轻烧伤后增生性瘢痕患者来源成纤维细胞的瘢痕形成。
Int J Mol Sci. 2025 Jun 19;26(12):5876. doi: 10.3390/ijms26125876.
3
Laser therapy for treating hypertrophic and keloid scars.激光疗法治疗增生性瘢痕和瘢痕疙瘩。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD011642. doi: 10.1002/14651858.CD011642.pub2.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Dahuang Zhechong Pill Improves Pulmonary Fibrosis through miR-29b-2-5p/HK2 Mediated Glycolysis Pathway.大黄蛰虫丸通过miR-29b-2-5p/己糖激酶2介导的糖酵解途径改善肺纤维化。
Chin J Integr Med. 2024 Sep 5. doi: 10.1007/s11655-024-3765-x.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
Silicone gel sheeting for treating hypertrophic scars.硅凝胶片治疗增生性瘢痕。
Cochrane Database Syst Rev. 2021 Sep 26;9(9):CD013357. doi: 10.1002/14651858.CD013357.pub2.
9
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
Circadian rhythm of cutaneous pruritus.皮肤瘙痒的昼夜节律。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Feb 28;49(2):190-196. doi: 10.11817/j.issn.1672-7347.2024.230397.
2
miRSNP rs188493331: A key player in genetic control of microRNA-induced pathway activation in hypertrophic scars and keloids.miRSNP rs188493331:在肥厚性瘢痕和瘢痕疙瘩中 miRNA 诱导通路激活的遗传控制中的关键因素。
Skin Res Technol. 2024 May;30(5):e13686. doi: 10.1111/srt.13686.
3
Differential Photosensitivity of Fibroblasts Obtained from Normal Skin and Hypertrophic Scar Tissues.
正常皮肤和增生性瘢痕组织成纤维细胞的光敏感性差异。
Int J Mol Sci. 2024 Feb 9;25(4):2126. doi: 10.3390/ijms25042126.
4
BMAL1 inhibits renal fibrosis and renal interstitial inflammation by targeting the ERK1/2/ELK-1/Egr-1 axis.BMAL1 通过靶向 ERK1/2/ELK-1/Egr-1 轴抑制肾纤维化和肾间质炎症。
Int Immunopharmacol. 2023 Dec;125(Pt B):111140. doi: 10.1016/j.intimp.2023.111140. Epub 2023 Nov 10.
5
Downregulation of a potential therapeutic target NPAS2, regulated by p53, alleviates pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via suppressing HES1.由p53调控的潜在治疗靶点NPAS2的下调,通过抑制HES1来抑制上皮-间质转化,从而减轻肺纤维化。
Cell Signal. 2023 Sep;109:110795. doi: 10.1016/j.cellsig.2023.110795. Epub 2023 Jul 3.
6
Disruption of the Clock Component Bmal1 in Mice Promotes Cancer Metastasis through the PAI-1-TGF-β-myoCAF-Dependent Mechanism.破坏小鼠生物钟组件 Bmal1 通过 PAI-1-TGF-β-myCAF 依赖性机制促进癌症转移。
Adv Sci (Weinh). 2023 Aug;10(24):e2301505. doi: 10.1002/advs.202301505. Epub 2023 Jun 17.
7
An Updated Review of Hypertrophic Scarring.增生性瘢痕的最新综述。
Cells. 2023 Feb 21;12(5):678. doi: 10.3390/cells12050678.
8
mA methylation-induced NR1D1 ablation disrupts the HSC circadian clock and promotes hepatic fibrosis.甲基化诱导的NR1D1缺失破坏造血干细胞生物钟并促进肝纤维化。
Pharmacol Res. 2023 Mar;189:106704. doi: 10.1016/j.phrs.2023.106704. Epub 2023 Feb 20.
9
Hypertrophic Scars and Keloids: Advances in Treatment and Review of Established Therapies.增生性瘢痕和瘢痕疙瘩:治疗进展及现有疗法综述
Am J Clin Dermatol. 2023 Mar;24(2):225-245. doi: 10.1007/s40257-022-00744-6. Epub 2023 Jan 20.
10
Role of Circadian Transcription Factor Rev-Erb in Metabolism and Tissue Fibrosis.昼夜节律转录因子 Rev-Erb 在代谢和组织纤维化中的作用。
Int J Mol Sci. 2022 Oct 26;23(21):12954. doi: 10.3390/ijms232112954.